AGP Executive Report
Last update: 4 hours agoPlant-based food quality: A large French study in The Lancet found that plant-based diets built on whole, minimally processed foods cut coronary heart disease risk, while plant-based diets heavy in ultra-processed supermarket foods raised risk. Sleep & heart health: Research in the European Heart Journal links higher light exposure at night with thicker heart walls and weaker pumping function, using wrist light sensors and heart scans. Food & nutrition basics: A new explainer highlights lentils as a high-protein, high-fibre staple tied to better blood sugar and heart outcomes. Rare disease drug approval: The FDA approved apitegromab (Isembyld) for spinal muscular atrophy, expanding options for adults and children. Cardio device update: Japan approved Elixir Medical’s DynamX Coronary Bioadaptor system for coronary artery disease after PCI. Healthcare industry moves: Sanofi and Cheplapharm plan a strategic partnership transferring 20 mature medicines and three sites. Public health policy: UK food and drink firms pledge voluntary “healthier food sales” reporting ahead of possible mandatory rules. Military health: Germany reported 31% of volunteer recruits medically unfit in Q2 2026, up from about 25% earlier in the year. Online safety for kids: France and the EU push EU-wide limits on children’s social media use under 15.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
